ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer

NCT03294889 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Geneva

Collaborators